Europe Hemophilia Management Market by Type (Hemophilia A, Hemophilia B) by Drug (Octocogalfa, Nonacogalfa, Desmopressin and other drugs) - Industry Analysis, Size, Share, Growth, Trends, and Forecasts(2016–2021)

Europe Hemophilia Management Market by Type (Hemophilia A, Hemophilia B) by Drug (Octocogalfa, Nonacogalfa, Desmopressin and other drugs) - Industry Analysis, Size, Share, Growth, Trends, and Forecasts(2016–2021)

ID: 312 | Pages: 141 | December 2016 | Region: Europe


The Europe Hemophilia Management Market was worth $1.24 billion in 2015 and estimated to be growing at a CAGR of 1.54%, to reach $1.34 billion by 2020. Hemophilia is a genetic disorder which impairs body`s ability to control blood clotting. Hemophilia usually occurs in males it is estimated that about 1 in 5000 males that are born each year contain hemophilia. Hemophilia is categorized into three levels depending on its severity as severe, moderate and mild. About 80% of the hemophilia patients are considered to suffer from severe type. The worldwide incidence of hemophilia is estimated at more than 400,000 people.

Europe Hemophilia Management market is driven by factors such as growing prevalence of the haemophilia A and haemophilia B, increasing government support and increasing usage of recombinant products. Technological advancements along with rising investments in Research and developments for hemophilia products are also some of the key factors fuelling the growth of the market. However stringent regulatory policies, lack of available medication high cost of treatment are the major factors hindering the growth of the market. Advancements in gene therapy and approaching approval of drugs for treatment of hemophilia provide immense growth opportunities in the market.

Europe Hemophilia management market is segmented on the basis of type of hemophilia and type of drug. By type of hemophilia it is further sub segmented into Hemophilia A and Hemophilia B. On the basis of drug type it is further sub segmented into Octocogalfa, Nonacogalfa, Desmopressin and other drugs. Hemophilia A is projected to have the highest growth rate driven by large number of patients suffering from hemophilia A

Based on geography Europe hemophilia management market is analyzed under various regions namely United Kingdom, Germany, Italy, France and Spain. Europe is the second largest market for hemophilia management. Within Europe, United Kingdom is the largest market for hemophilia management accounting for a share of approximately XX% due to huge government support. Germany is estimated to be the fastest growing region with a highest CAGR of XX% owing to increasing disease burden.

Some of the major companies discussed in the report are Biogen, Baxter International Inc., Pfizer Inc., Bayer Pharma AG, Novo Nordisk A/S, Grifols International SA, CSL Behring, Octapharma and Swedish Orphan Biovitrum AB

  1. Introduction

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

  1. Market Segmentation

                5.1 BY Type                                        

                                5.1.1 Hemophilia A                         

                                5.1.2 Hemophilia B                          

                5.2 By Drug                                        

                                5.2.1 Octocogalfa                            

                                5.2.2 Nonacogalfa                           

                                5.2.3 Desmopressin                       

                                5.2.4 Other drugs                            

  1. Geographical Analysis

                                6.1 Introduction                               

                                6.2 U.K                 

                                6.3 Spain                             

                                6.4 Germany                     

                                6.5 Italy                               

                                6.6 France                          

  1. Strategic Analysis

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

  1. Market Leaders' Analysis

                8.1 Biogen                                          

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Pfizer Inc.                                    

                8.3 Baxter International Inc.                                       

                8.4 Bayer Pharma AG                                    

                8.5 Novo Nordisk A/S                                    

                8.6 Grifols International SA                                         

                8.7 CSL Behring                                

                8.8 Octapharma                                               

                8.9 Swedish Orphan Biovitrum AB                                           

  1. Competitive Landscape

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

  1. Expert Opinions

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

     Appendix                                                          

a) List of Tables

b) List of Figures

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Hemophilia Management Market By Region, From 2015-2020 (USD Million)
  2. Europe Hemophilia Management Market By Type, From 2015-2020 (USD Million)
  3. Europe Hemophilia-A Market By Region, From 2015-2020 (USD Million)
  4. Europe Hemophilia-B Market By Region, From 2015-2020 (USD Million)
  5. Europe Hemophilia Management Market By Drug, From 2015-2020 (USD Million)
  6. Europe Octocogalfa Market By Region, From 2015-2020 (USD Million)
  7. Europe Nonacogalfa Market By Region, From 2015-2020 (USD Million)
  8. Europe Desmopressin Market By Region, From 2015-2020 (USD Million)
  9. Europe Other drugs Market By Region, From 2015-2020 (USD Million)
  10. U.K Hemophilia Management Market By Type, From 2015-2020 (USD Million)
  11. U.K Hemophilia Management Market By Drug, From 2015-2020 (USD Million)
  12. Spain Hemophilia Management Market By Type, From 2015-2020 (USD Million)
  13. Spain Hemophilia Management Market By Drug, From 2015-2020 (USD Million)
  14. Germany Hemophilia Management Market By Type, From 2015-2020 (USD Million)
  15. Germany Hemophilia Management Market By Drug, From 2015-2020 (USD Million)
  16. Italy Hemophilia Management Market By Type, From 2015-2020 (USD Million)
  17. Italy Hemophilia Management Market By Drug, From 2015-2020 (USD Million)
  18. France Hemophilia Management Market By Type, From 2015-2020 (USD Million)
  19. France Hemophilia Management Market Market By Drug, From 2015-2020 (USD Million)
Middle East And Africa Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth...
Latin America Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) –Latin America Industry Analysis, Size, Share, Gr...
Asia Pacific Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth, Trends, ...
Europe Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth, Trends,...
Surface Plasmon Resonance Market By Product (Sensor System And Reagent , Imaging System) By Application (Material Sciences, Drug Discovery, Biosensor), And By Region - Global Industry Analysis, Size, Share, Growth, ...
Middle East And Africa Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
Latin America Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
Asia Pacific Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
Europe Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
North America Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
Blood Brain Barrier Technologies Market By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.